← Back to all signals
RESEARCH PAPER ANALYSIS

New staging criteria predicting m-tor inhibitors treatment effect of renal angiomyolipoma in tuberous sclerosis complex patients.

AI interpretation is pending for this paper.

Open original publication →
PMID39302433
JournalWorld journal of urology
Publication Date2024-09-20
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: We aimed to launched new staging criteria to predict mTOR inhibitors treatment effect of renal angiomyolipomas (r-AMLs) in TSC patients. METHODS: 40 TSC patients with 69 r-AMLs were divided into two groups based on the efficacy of 6-month mTOR inhibitor treatment. Epidemiological data, therapeutic response, and predictive factors of enrolled patients were collected and analyzed. Age, sex, maximum diameter, maximum cross-sectional area (CSAmax), unenhanced mean CT value, enhanced mean CT value, and added value of enhanced CT of largest r-AML at baseline were assessed as potential influencing factors. Receiver operating characteristic (ROC) curve analysis and the area under the ROC curve (AUC) was used to estimate prediction power. RESULTS: After 6 months of mTOR inhibitor treatment, the tumor reduction rates in the two groups were 55.87% and 16.44% (P < 0.001). At the start of treatment, the maximum diameters, CSAmax, added value of enhanced CT of the target lesion in two groups were 7.70 ± 0.73 cm vs. 13.18 ± 1.23 cm(P = 0.028), 57.40 ± 10.76cm2 vs. 167.29 ± 33.09cm2 (P = 0.015), and 62.32 ± 5.03HU vs. 33.06 ± 3.13HU (P = 0.009), respectively. AUCs of CSAmax, added value of enhanced CT, and combination of both were 0.8024, 0.7672, and 0.8116, respectively (P < 0.001). Cut-off values of CSAmax combined with the added value of enhanced CT were 40cm2 and 46HU. AUCs of maximum diameters, combination of maximum diameters and added value of enhanced CT were 0.7600 and 0.8100, respectively (P < 0.001), with cut-off values of 6.6 cm and 46 HU. CONCLUSION: New staging criteria, based on CSAmax and added value of enhanced CT, can predict the treatment efficiency of m-TOR inhibitors for r-AMLs in TSC patients. A simplified version based on maximum diameter and added value of enhanced CT of lesion has also been proposed.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors. Neuro-oncology advances 56.94 2 Delayed Detection of Bilateral High-Frequency Sensorineural Hearing Loss Following Childhood Cisplatin Therapy: A Case Report. The journal of international advanced otology 59.94 3 Conservative Management of a Primary Mandibular Second Molar With Dentoalveolar Abscess in a Four-Year-Old Child With Acute Lymphoblastic Leukemia: A Case Report. Cureus 54.3 4 Machine Learning Comparison and Combined Model Optimization Based on DCE-MRI Radiomics for Preoperative Assessment of Lymphovascular Invasion in Breast Cancer: A Multicenter Study. Cancer reports (Hoboken, N.J.) 65.9 5 Pediatric ALK-Negative Anaplastic Large Cell Lymphoma With Recurrent Cutaneous Relapses: Diagnostic Challenges. Pediatric dermatology 61.62 6 A safety review of jak inhibitors for managing alopecia areata. Expert opinion on drug safety 74.06 7 Support for Disclosure of Hereditary Tumor Risk to Children and Adolescents: A Scoping Review. Japan journal of nursing science : JJNS 78.4 8 Late Ischemic Cholangiopathy After Liver Transplantation From a Deceased Donor With Situs Inversus Totalis: A Case Report. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 47.5 9 Lived experiences of parenting-related distress in mothers with gynecological cancer: a descriptive phenomenological study. BMC women's health 58.4 10 Vancomycin Taper-and-Pulse Therapy for Recurrent Clostridioides difficile Infection in Pediatric Acute Lymphoblastic Leukemia Patients Treated With Blinatumomab and Chemotherapy: A Report of Three Cases. Cureus 62.34 11 Percutaneous calcium phosphate cement injection for unicameral bone cysts: mid- to long-term clinical and radiographic outcomes. Frontiers in surgery 63.9 12 Radiographic evidence of thymic involution in hepatocellular carcinoma: a propensity score-matched study in viral cirrhosis. Frontiers in immunology 62.5 13 Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clue. Frontiers in immunology 56.6 14 Herpes zoster frequency and severity in immunocompromised pediatric populations: a structured narrative review. Frontiers in pediatrics 59.0 15 Recognition and management of early complications in CAR-T cell therapy and virus-specific T-lymphocyte therapy: a practical clinical reference. Frontiers in immunology 75.5 16 Gastric dysbiosis and more severe histological gastritis in symptomatic Helicobacter pylori-infected children and adolescents without ulcers: time to rethink early eradication? Frontiers in microbiology 58.4 17 Surgical management and molecular diagnosis of pediatric cystic nephroma: a single-center case series with implications for DICER1 syndrome surveillance. Translational andrology and urology 56.9 18 Infantile Osteopetrosis with a CLCN7 Variant: An Educational Case Highlighting Integrated Diagnosis and Variant Interpretation. EJIFCC 56.0 19 Plexiform neurofibroma of the scrotum in a 16-year-old male: A case report. Urology case reports 45.5 20 Advanced Imaging Techniques for Early in-Vivo Discrimination of Fibrofolliculomas in Birt-Hogg-Dubé Syndrome. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 57.5 21 Health Behaviors in Adolescent and Young Adult (AYA) Childhood Cancer Survivors: Prevalence, Determinants, and Comparison With Population Controls. Cancer medicine 66.9 22 Mechanism of Gu-Ben-Hua-Shi (AESS) Formula Regulating Autophagy Through Hippo-YAP Pathway in Restoring the Skin Barrier in Atopic Dermatitis. Journal of cellular and molecular medicine 76.35 23 Mapping Psychosocial Determinants for Cancer Onset: An Umbrella Review. Psycho-oncology 74.9 24 Early-onset colorectal cancer burden attributable to early-life obesity from 2000 to 2020 with projections to 2040. Cancer epidemiology 57.5 25 The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers. The Journal of molecular diagnostics : JMD 59.6 26 GATA3-driven CDC20 activation facilitates tumor growth and metastasis through suppressing Bax/Bcl-2 ratio and boosting EMT process in neuroblastoma. The Journal of biological chemistry 60.6 27 [Masked pediatric pathological femoral fracture : Case report of a sarcoma-associated femoral fracture after adequate trauma]. Unfallchirurgie (Heidelberg, Germany) 49.9 28 Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study. Hepatology international 61.1 29 Privacy-Preserving Linkage of Distributed Biological, Clinical, and Imaging Data Supporting Artificial Intelligence in Pediatric Oncology. Methods of information in medicine 71.9 30 Risk and benefit for targeted therapy agents in paediatric phase I trials in oncology: a systematic review and meta-analysis protocol. BMJ open 83.72 31 Testicular Tissue Cryopreservation in Prepubertal Boys: Current Advances, Clinical Feasibility, and Future Directions-A Comprehensive Literature Review. Andrology 63.6 32 Opioid limiting law and opioid prescriptions among Medicaid-enrolled survivors of childhood cancer. Journal of the National Cancer Institute 57.5
PATIENT-FRIENDLY SUMMARY

New staging criteria predicting m-tor inhibitors treatment effect of renal angiomyolipoma in tuberous sclerosis complex patients.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic